Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children?
Status:
Completed
Trial end date:
2018-12-04
Target enrollment:
Participant gender:
Summary
An open-label (outcome assessor blinded) prospective crossover cohort study of children 6-16
years assessing effects of Montelukast on moderate to severe atopic dermatitis.